Senior insider sale
Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$157.7K
42.77K shares
What this filing means
TAYLOR BEN R plans to sell 42.77K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $157.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002399
Officer· Chief Financial Officer
Since Feb 2026
42.77K
Shares to sell
$157.7K
Approx. market value
7.96K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/15/2026
7.96KTotal acquired7.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2026 | Restricted Stock Vesting Compensation | 7.96K | — |
| Total | 7.96K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
13.43K
Market value
$41.4K
2/18/2026
—Completed
Units to sell
21.38K
Market value
$89.4K
12/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.96K
Market value
$27.0K
3/17/2026
Total
Units
42.77K
Value
$157.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 13.43K | $41.4K | — | Completed |
12/29/2025 | 21.38K | $89.4K | — | Completed |
| Planned — Approximate Date | ||||
3/17/2026 | 7.96K | $27.0K | NASDAQ | Planned |
| Total | 42.77K | $157.7K | ||